Ondansetron market penetration rate
MedAnalytics measures Ondansetron
market penetration in different
The report is often a source of untapped
market potentials that may exist around your own business.
The market penetration of Ondansetron varied in different clinical practice.
In recent year 2019, market penetrations was
in Neurosurgeons, 13% in General Physicians, 12% in Pediatric Surgeons,
12% in Orthopaedic Surgeons, 12% in Internal Medicine Specialists, 11%
in Gynecologists & Obstetricians, 10% in Plastic Surgeons, 10% in
Nephrologists, 10% in Diabetologists, 9% in hepatobiliary surgeons, 9%
in Gastroenterologists, 9% in ophthalmologists, 9% in Dermatologists, 8%
in Infertility Specialists, 8% in Urologists, 8% in Psychiatrists, 8%
in Neurologists, 8% in ENT Specialists, 8% in Rheumatology Specialists,
8% in General & Laparoscopic Surgeons, 8% in Respiratory Medicine
Specialists, 8% in Cardiologists, 7% in Critical Care Medicine
Specialists, 6% in Colorectal Surgeons, 6% in Physical Medicine
Specialists, 6% in Dentists and 5% in cancer surgeons.
You might be interested to our other reports
Get Registered for more detail